These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21554525)
21. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study. Lange U; Teichmann J; Müller-Ladner U; Strunk J Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785 [TBL] [Abstract][Full Text] [Related]
22. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205 [TBL] [Abstract][Full Text] [Related]
23. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women. Liu SZ; Tian LF; Xu P; Zhuang GH; Zheng F; Tian J; Ning QL; Zhu BF; Lu SM; Yan H Mol Biol Rep; 2011 Feb; 38(2):939-48. PubMed ID: 20490690 [TBL] [Abstract][Full Text] [Related]
24. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449 [TBL] [Abstract][Full Text] [Related]
25. Low bone mass in idiopathic renal stone formers: magnitude and significance. Jaeger P; Lippuner K; Casez JP; Hess B; Ackermann D; Hug C J Bone Miner Res; 1994 Oct; 9(10):1525-32. PubMed ID: 7817797 [TBL] [Abstract][Full Text] [Related]
26. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF; Geyikli I; Yazgan P; Celik A Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321 [TBL] [Abstract][Full Text] [Related]
27. Bone mineral density changes within 11 months of renal transplantation in Iranian patients. Bayat N; Einollahi B; Pourfarzian V; Alishiri G; Nemati E; Bagheri N; Miri SM; Elizeii PK Transplant Proc; 2007 May; 39(4):1039-43. PubMed ID: 17524886 [TBL] [Abstract][Full Text] [Related]
28. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator. Arshad M; Sengupta S; Sharma S; Ghosh R; Sawlani V; Singh MM J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):67-78. PubMed ID: 15261309 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Akin O; Göl K; Aktürk M; Erkaya S Gynecol Endocrinol; 2003 Feb; 17(1):19-29. PubMed ID: 12724015 [TBL] [Abstract][Full Text] [Related]
30. Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management. Arrabal-Polo MA; Cano-García Mdel C; Canales BK; Arrabal-Martín M Curr Opin Urol; 2014 Nov; 24(6):633-8. PubMed ID: 25188231 [TBL] [Abstract][Full Text] [Related]
31. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Löfman O; Magnusson P; Toss G; Larsson L Clin Chim Acta; 2005 Jun; 356(1-2):67-75. PubMed ID: 15936304 [TBL] [Abstract][Full Text] [Related]
32. Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis. Girón-Prieto MS; Arias-Santiago S; Del Carmen Cano-García M; Poyatos-Andújar A; de Haro-Muñoz T; Abad-Menor F; Quesada-Charneco M; Arrabal-Polo MÁ; Arrabal-Martín M Int Urol Nephrol; 2016 Nov; 48(11):1777-1781. PubMed ID: 27376897 [TBL] [Abstract][Full Text] [Related]
33. Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China. Guo Q; Fan P; Luo J; Wu S; Sun H; He L; Zhou B Lupus; 2017 Mar; 26(3):289-293. PubMed ID: 27522093 [TBL] [Abstract][Full Text] [Related]
34. [Bone metabolism in dialysis patient assessed by biochemical markers and densitometry]. Małyszko J; Brzósko S; Wołczyński S; Małyszko JS; Myśliwiec M Pol Arch Med Wewn; 2003 Sep; 110(3):967-72. PubMed ID: 14699689 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow sFRP5 level is negatively associated with bone formation markers. Chen H; He Y; Wu D; Dai G; Zhao C; Huang W; Jiang D Osteoporos Int; 2017 Apr; 28(4):1305-1311. PubMed ID: 27986984 [TBL] [Abstract][Full Text] [Related]
36. [Linear regression analysis of values of the calciuria index, N-telopetide and bone mineral density in patients with osteoporosis]. Wendlová J; Mikulecký M; Rácová K Vnitr Lek; 1999 Mar; 45(3):159-62. PubMed ID: 15641239 [TBL] [Abstract][Full Text] [Related]
37. Bone mineral density and changes in bone metabolism in patients with obstructive sleep apnea syndrome. Terzi R; Yılmaz Z J Bone Miner Metab; 2016 Jul; 34(4):475-81. PubMed ID: 26204846 [TBL] [Abstract][Full Text] [Related]
38. Effect of phytate on hypercalciuria secondary to bone resorption in patients with urinary stones: pilot study. Guimerà J; Martínez A; Bauza JL; Sanchís P; Pieras E; Grases F Urolithiasis; 2022 Dec; 50(6):685-690. PubMed ID: 36087116 [TBL] [Abstract][Full Text] [Related]
39. CT-Based Diagnosis of Low Vertebral Bone Mineral Density Is Associated with Hypercalciuria and Hypocitraturia on Opportunistic Imaging. Patel ND; Ward RD; Calle J; Remer EM; Monga M J Endourol; 2018 Sep; 32(9):878-883. PubMed ID: 29954225 [TBL] [Abstract][Full Text] [Related]
40. Osteopenia/osteoporosis in patients with calcium nephrolithiasis. Arrabal-Polo MA; Arrabal-Martin M; Girón-Prieto MS; Poyatos-Andujar A; Garrido-Gomez J; Zuluaga-Gomez A; Arias-Santiago S Urol Res; 2012 Dec; 40(6):709-16. PubMed ID: 22886308 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]